A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors
Recruiting · NCT05366478 · Registry updated 2022-08-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Clinical Study of LM103 Injection in the Treatment of Advanced Solid Tumors | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, Uterine Cervical Neoplasms, bronchial neoplasm, bronchogenic carcinoma, cervical carcinoma, cervix disorder, female reproductive system disorder, female reproductive system neoplasm, lung disorder, lung neoplasm, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, respiratory system disorder, respiratory tract neoplasm, skin disorder, skin neoplasm, uterine disorder | Recruiting | Phase 1 | 2022-08-02 | NCT05366478 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Suzhou BlueHorse Therapeutics Co., Ltd. | 5 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tianjin Beichen Hospital | Tianjin | China | 2 |